vfa Forecasts German Pharma Output to Fall 2.2% in 2026
Bitget2026/10/23 09:40- German pharmaceutical production is forecast to fall 2.2% in 2026, before rebounding 4.3% in 2027, largely on catch-up effects.
- Pharmaceutical investment spending is projected to decline 1.8% in nominal terms in 2027 as statutory cost-cutting measures squeeze profitability.
- Cumulative capital investment and research spending could be more than €4 billion below levels without the additional burdens by 2030.
- The mandatory manufacturer rebate on patent-protected medicines rises from 7% to 15.5% at the start of 2027, reducing investment returns.
- Germany’s economy is forecast to grow 1.3% in 2026, slowing to 1.1% in 2027, with private investment remaining weak.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
After the sharp decline in tech stocks, the White House suddenly canceled the top tech advisor meeting the following day.
The White House has canceled the previously scheduled President’s Council of Advisors on Science and Technology meeting, which was set for Friday and includes prominent tech leaders such as Nvidia CEO Jensen Huang and Meta CEO Mark Zuckerberg. The Department of Energy's meeting page briefly listed November 13 as the new meeting date, but the agency later sent an email retracting this information. Currently, the specific date for rescheduling the meeting remains unclear.
Turtle Creek Asset Management Reports Sale of $347,850 in Jeld-Wen Common Shares
GLOBALFOUNDRIES Director Ganesh Moorthy Reports $93,687.50 Share Acquisition
Crypto prices
More
